Mancini M - Search Results

1

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice.

Davis HL, Brazolot Millan CL, Mancini M, McCluskie MJ, Hadchouel M, Comanita L, Tiollais P, Whalen RG, Michel ML. Davis HL, et al. Among authors: mancini m. Vaccine. 1997 Jun;15(8):849-52. doi: 10.1016/s0264-410x(96)00267-8. Vaccine. 1997. PMID: 9234531

2

Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen.

Davis HL, Michel ML, Mancini M, Schleef M, Whalen RG. Davis HL, et al. Among authors: mancini m. Vaccine. 1994 Dec;12(16):1503-9. doi: 10.1016/0264-410x(94)90073-6. Vaccine. 1994. PMID: 7879414

3

Comparison of plasmid DNA preparation methods for direct gene transfer and genetic immunization.

Davis HL, Schleef M, Moritz P, Mancini M, Schorr J, Whalen RG. Davis HL, et al. Among authors: mancini m. Biotechniques. 1996 Jul;21(1):92-4, 96-9. doi: 10.2144/96211st03. Biotechniques. 1996. PMID: 8816242 Free article.

4

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

Davis HL, Mancini M, Michel ML, Whalen RG. Davis HL, et al. Among authors: mancini m. Vaccine. 1996 Jun;14(9):910-5. doi: 10.1016/0264-410x(95)00255-y. Vaccine. 1996. PMID: 8843634

5

Immunization with a plasmid encoding a modified hepatitis B surface antigen carrying the receptor binding site for hepatocytes.

Hui J, Mancini M, Li G, Wang Y, Tiollais P, Michel ML. Hui J, et al. Among authors: mancini m. Vaccine. 1999 Mar 26;17(13-14):1711-8. doi: 10.1016/s0264-410x(98)00430-7. Vaccine. 1999. PMID: 10194827

6

Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates.

Schlienger K, Mancini M, Rivière Y, Dormont D, Tiollais P, Michel ML. Schlienger K, et al. Among authors: mancini m. J Virol. 1992 Apr;66(4):2570-6. doi: 10.1128/JVI.66.4.2570-2576.1992. J Virol. 1992. PMID: 1548782 Free PMC article.

7

Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg.

Mancini M, Hadchouel M, Tiollais P, Pourcel C, Michel ML. Mancini M, et al. J Med Virol. 1993 Jan;39(1):67-74. doi: 10.1002/jmv.1890390113. J Med Virol. 1993. PMID: 7678639

8

Recombinant hepatitis B surface antigen as a carrier of human immunodeficiency virus epitopes.

Michel ML, Mancini M, Schlienger K, Tiollais P. Michel ML, et al. Among authors: mancini m. Res Virol. 1993 Jul-Aug;144(4):263-7. doi: 10.1016/s0923-2516(06)80038-5. Res Virol. 1993. PMID: 7692575

9

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.

Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG. Michel ML, et al. Among authors: mancini m. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5307-11. doi: 10.1073/pnas.92.12.5307. Proc Natl Acad Sci U S A. 1995. PMID: 7777503 Free PMC article.

10

Immunogenicity of hybrid hepatitis B surface antigen particles.

Mancini M, Schlienger K, Tiollais P, Michel ML. Mancini M, et al. Int Rev Immunol. 1994;11(2):143-51. doi: 10.3109/08830189409061722. Int Rev Immunol. 1994. PMID: 8046275 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,409 results

Search Page

Filters